Superoxide Dismutase Mimetic GC4419 Enhances the Oxidation of Pharmacological Ascorbate and Its Anticancer Effects in an H2O2-Dependent Manner
Lung cancer, together with head and neck cancer, accounts for more than one-fourth of cancer deaths worldwide. New, non-toxic therapeutic approaches are needed. High-dose IV vitamin C (aka, pharmacological ascorbate; P-AscH−) represents a promising adjuvant to radiochemotherapy that exerts its anti-...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2018-01-01
|
| Series: | Antioxidants |
| Subjects: | |
| Online Access: | http://www.mdpi.com/2076-3921/7/1/18 |
| _version_ | 1797728719694987264 |
|---|---|
| author | Collin D. Heer Andrew B. Davis David B. Riffe Brett A. Wagner Kelly C. Falls Bryan G. Allen Garry R. Buettner Robert A. Beardsley Dennis P. Riley Douglas R. Spitz |
| author_facet | Collin D. Heer Andrew B. Davis David B. Riffe Brett A. Wagner Kelly C. Falls Bryan G. Allen Garry R. Buettner Robert A. Beardsley Dennis P. Riley Douglas R. Spitz |
| author_sort | Collin D. Heer |
| collection | DOAJ |
| description | Lung cancer, together with head and neck cancer, accounts for more than one-fourth of cancer deaths worldwide. New, non-toxic therapeutic approaches are needed. High-dose IV vitamin C (aka, pharmacological ascorbate; P-AscH−) represents a promising adjuvant to radiochemotherapy that exerts its anti-cancer effects via metal-catalyzed oxidation to form H2O2. Mn(III)-porphyrins possessing superoxide dismutase (SOD) mimetic activity have been shown to increase the rate of oxidation of AscH−, enhancing the anti-tumor effects of AscH− in several cancer types. The current study demonstrates that the Mn(II)-containing pentaazamacrocyclic selective SOD mimetic GC4419 may serve as an AscH−/O2•− oxidoreductase as evidenced by the increased rate of oxygen consumption, steady-state concentrations of ascorbate radical, and H2O2 production in complete cell culture media. GC4419, but not CuZnSOD, was shown to significantly enhance the toxicity of AscH− in H1299, SCC25, SQ20B, and Cal27 cancer cell lines. This enhanced cancer cell killing was dependent upon the catalytic activity of the SOD mimetic and the generation of H2O2, as determined using conditional overexpression of catalase in H1299T cells. GC4419 combined with AscH− was also capable of enhancing radiation-induced cancer cell killing. Currently, AscH− and GC4419 are each being tested separately in clinical trials in combination with radiation therapy. Data presented here support the hypothesis that the combination of GC4419 and AscH− may provide an effective means by which to further enhance radiation therapy responses. |
| first_indexed | 2024-03-12T11:18:04Z |
| format | Article |
| id | doaj.art-ceb651bc27ea41a49bd9dd8355de159b |
| institution | Directory Open Access Journal |
| issn | 2076-3921 |
| language | English |
| last_indexed | 2024-03-12T11:18:04Z |
| publishDate | 2018-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Antioxidants |
| spelling | doaj.art-ceb651bc27ea41a49bd9dd8355de159b2023-09-02T01:42:38ZengMDPI AGAntioxidants2076-39212018-01-01711810.3390/antiox7010018antiox7010018Superoxide Dismutase Mimetic GC4419 Enhances the Oxidation of Pharmacological Ascorbate and Its Anticancer Effects in an H2O2-Dependent MannerCollin D. Heer0Andrew B. Davis1David B. Riffe2Brett A. Wagner3Kelly C. Falls4Bryan G. Allen5Garry R. Buettner6Robert A. Beardsley7Dennis P. Riley8Douglas R. Spitz9Free Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, The University of Iowa College of Medicine, Iowa City, IA 52242, USAFree Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, The University of Iowa College of Medicine, Iowa City, IA 52242, USAFree Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, The University of Iowa College of Medicine, Iowa City, IA 52242, USAFree Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, The University of Iowa College of Medicine, Iowa City, IA 52242, USAFree Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, The University of Iowa College of Medicine, Iowa City, IA 52242, USAFree Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, The University of Iowa College of Medicine, Iowa City, IA 52242, USAFree Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, The University of Iowa College of Medicine, Iowa City, IA 52242, USAGalera Therapeutics, Malvern, PA 19355, USAGalera Therapeutics, Malvern, PA 19355, USAFree Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, The University of Iowa College of Medicine, Iowa City, IA 52242, USALung cancer, together with head and neck cancer, accounts for more than one-fourth of cancer deaths worldwide. New, non-toxic therapeutic approaches are needed. High-dose IV vitamin C (aka, pharmacological ascorbate; P-AscH−) represents a promising adjuvant to radiochemotherapy that exerts its anti-cancer effects via metal-catalyzed oxidation to form H2O2. Mn(III)-porphyrins possessing superoxide dismutase (SOD) mimetic activity have been shown to increase the rate of oxidation of AscH−, enhancing the anti-tumor effects of AscH− in several cancer types. The current study demonstrates that the Mn(II)-containing pentaazamacrocyclic selective SOD mimetic GC4419 may serve as an AscH−/O2•− oxidoreductase as evidenced by the increased rate of oxygen consumption, steady-state concentrations of ascorbate radical, and H2O2 production in complete cell culture media. GC4419, but not CuZnSOD, was shown to significantly enhance the toxicity of AscH− in H1299, SCC25, SQ20B, and Cal27 cancer cell lines. This enhanced cancer cell killing was dependent upon the catalytic activity of the SOD mimetic and the generation of H2O2, as determined using conditional overexpression of catalase in H1299T cells. GC4419 combined with AscH− was also capable of enhancing radiation-induced cancer cell killing. Currently, AscH− and GC4419 are each being tested separately in clinical trials in combination with radiation therapy. Data presented here support the hypothesis that the combination of GC4419 and AscH− may provide an effective means by which to further enhance radiation therapy responses.http://www.mdpi.com/2076-3921/7/1/18SOD mimeticpharmacological ascorbatevitamin Chead and neck cancerlung cancerradiation therapyGC4419oxidative stresshydrogen peroxide |
| spellingShingle | Collin D. Heer Andrew B. Davis David B. Riffe Brett A. Wagner Kelly C. Falls Bryan G. Allen Garry R. Buettner Robert A. Beardsley Dennis P. Riley Douglas R. Spitz Superoxide Dismutase Mimetic GC4419 Enhances the Oxidation of Pharmacological Ascorbate and Its Anticancer Effects in an H2O2-Dependent Manner Antioxidants SOD mimetic pharmacological ascorbate vitamin C head and neck cancer lung cancer radiation therapy GC4419 oxidative stress hydrogen peroxide |
| title | Superoxide Dismutase Mimetic GC4419 Enhances the Oxidation of Pharmacological Ascorbate and Its Anticancer Effects in an H2O2-Dependent Manner |
| title_full | Superoxide Dismutase Mimetic GC4419 Enhances the Oxidation of Pharmacological Ascorbate and Its Anticancer Effects in an H2O2-Dependent Manner |
| title_fullStr | Superoxide Dismutase Mimetic GC4419 Enhances the Oxidation of Pharmacological Ascorbate and Its Anticancer Effects in an H2O2-Dependent Manner |
| title_full_unstemmed | Superoxide Dismutase Mimetic GC4419 Enhances the Oxidation of Pharmacological Ascorbate and Its Anticancer Effects in an H2O2-Dependent Manner |
| title_short | Superoxide Dismutase Mimetic GC4419 Enhances the Oxidation of Pharmacological Ascorbate and Its Anticancer Effects in an H2O2-Dependent Manner |
| title_sort | superoxide dismutase mimetic gc4419 enhances the oxidation of pharmacological ascorbate and its anticancer effects in an h2o2 dependent manner |
| topic | SOD mimetic pharmacological ascorbate vitamin C head and neck cancer lung cancer radiation therapy GC4419 oxidative stress hydrogen peroxide |
| url | http://www.mdpi.com/2076-3921/7/1/18 |
| work_keys_str_mv | AT collindheer superoxidedismutasemimeticgc4419enhancestheoxidationofpharmacologicalascorbateanditsanticancereffectsinanh2o2dependentmanner AT andrewbdavis superoxidedismutasemimeticgc4419enhancestheoxidationofpharmacologicalascorbateanditsanticancereffectsinanh2o2dependentmanner AT davidbriffe superoxidedismutasemimeticgc4419enhancestheoxidationofpharmacologicalascorbateanditsanticancereffectsinanh2o2dependentmanner AT brettawagner superoxidedismutasemimeticgc4419enhancestheoxidationofpharmacologicalascorbateanditsanticancereffectsinanh2o2dependentmanner AT kellycfalls superoxidedismutasemimeticgc4419enhancestheoxidationofpharmacologicalascorbateanditsanticancereffectsinanh2o2dependentmanner AT bryangallen superoxidedismutasemimeticgc4419enhancestheoxidationofpharmacologicalascorbateanditsanticancereffectsinanh2o2dependentmanner AT garryrbuettner superoxidedismutasemimeticgc4419enhancestheoxidationofpharmacologicalascorbateanditsanticancereffectsinanh2o2dependentmanner AT robertabeardsley superoxidedismutasemimeticgc4419enhancestheoxidationofpharmacologicalascorbateanditsanticancereffectsinanh2o2dependentmanner AT dennispriley superoxidedismutasemimeticgc4419enhancestheoxidationofpharmacologicalascorbateanditsanticancereffectsinanh2o2dependentmanner AT douglasrspitz superoxidedismutasemimeticgc4419enhancestheoxidationofpharmacologicalascorbateanditsanticancereffectsinanh2o2dependentmanner |